Injective price traded near $5.64 after gaining more than 4%, extending its recovery from July lows near $4.00. The INJ token is now available on Solana through Sunrise and LayerZero infrastructure. The expansion gives Solana users access to INJ across supported applications. Technical momentum remains constructive, although resistance between $6.00 and $6.50 still limits the rebound.
The daily setup shows INJ peaked above $7.50 in early June before entering a steep decline. Price bottomed during July, then rebounded toward $6.50 in late August. A later pullback returned the token toward its current range.
RSI stands at 52.76, signalling neutral-to-slightly-bullish momentum after retreating from overbought territory. Immediate support sits between $5.00 and $5.20. A loss of $5.00 could expose $4.50.
Injective price needs a daily close above $6.50 to confirm further recovery. That move could first target $7.00 and then $8.00. Crypto Patel also identified longer-term levels at $15, $31, $53, and $100, but those remain speculative.
The analyst said INJ had risen 177% from his earlier accumulation zone. That performance is specific to his stated entry range, not the wider market. Reaching $100 would require gains exceeding 1,600% from current prices, highlighting the target’s long-term and highly uncertain nature.
Injective said INJ is officially live on Solana, allowing users to access the asset through supported applications. Developers can also launch tokens paired with INJ.
Injective price still depends on technical confirmation rather than the integration alone. Holding $5.00-$5.20 keeps recovery intact, while $6.50 remains the decisive barrier. A breakout would place $8 in focus before higher targets become relevant.